Earnings Call · Q2 FY2026·2026-08-04

Q2 26EPS -100.00%*·Rev n/aQ1 26EPS +100.00%*·Rev n/aQ4 25EPS +100.00%*·Rev n/aQ3 25EPS +100.00%*·Rev n/a⚠ consensus missing

Travere Therapeutics, Inc. TVTX

Nivi Nehra — Vice President, Corporate Communications and Investor Relations

Dr. Eric Dube — President and Chief Executive Officer

Peter Heerma — Chief Commercial Officer

Dr. Jula Inrig — Head of R&D and Chief Medical Officer

Chris Cline — Chief Financial Officer

+12.0%1d on move date3d+9.5%5d+7.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TVTX calls or request research access.

More TVTX calls Browse calls Request research access